Harvard Bioscience (HBIO) vs Retractable Technologies (RVP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Harvard Bioscience (HBIO) has outperformed Retractable Technologies (RVP) over the past year, gaining 87.3% versus a loss of 35.6%. Over five years, HBIO leads with a -88.0% price change compared with -92.7% for RVP. Harvard Bioscience is the larger company by market cap ($37.5 million vs $19.9 million), about 1.9 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HBIO | RVP |
|---|---|---|
| Share price | $8.24 | $0.6632 |
| Market cap | $37.51M | $19.85M |
| 1-day change | +1.35% | +0.18% |
| YTD return | +22.99% | -13.87% |
| 1-year return | +87.27% | -35.61% |
| 5-year return | -87.95% | -92.74% |
| Forward P/E | 12.78 | — |
| EPS (TTM) | $-2.31 | $-0.12 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $9.40 | $1.14 |
| 52-week low | $3.80 | $0.60 |
| Distance from 52-week high | -12.34% | -41.82% |
| Analyst consensus | none | — |
| Avg. price target upside | -8.98% | — |
| Average volume | 18.05K | 27.48K |
| Shares outstanding | 4.55M | 29.94M |
| Employees | 316 | 195 |
| Sector | Industrials | Health Care |
| Industry | Biotechnology: Laboratory Analytical Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- HBIO has outperformed RVP by 122.9 percentage points over the past year.
- The two companies sit in different sectors: Harvard Bioscience in Industrials and Retractable Technologies in Health Care.
About Harvard Bioscience
HBIO stock →Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally.
Industrials · Biotechnology: Laboratory Analytical Instruments · 316 employees
About Retractable Technologies
RVP stock →Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally.
Health Care · Medical/Dental Instruments · 195 employees
HBIO vs RVP FAQ
Which is bigger, Harvard Bioscience or Retractable Technologies?
Harvard Bioscience (HBIO) is larger, with a market capitalization of $37.51M compared with $19.85M for Retractable Technologies (RVP).
Which stock has performed better over the past year, HBIO or RVP?
HBIO returned +87.27% over the past 12 months, compared with -35.61% for RVP (price return, excluding dividends). Past performance does not predict future results.
Are Harvard Bioscience and Retractable Technologies in the same industry?
No. Harvard Bioscience is in the Industrials sector, while Retractable Technologies is in Health Care.